Key Highlights
- Shares closed at $17.72 at last closing, up 0.06%.
- Second-quarter 2026 Investment income was a record, with Earnings meeting estimates.
- The results contributed to first-half records for the company.
- Hercules Capital provides venture Debt and growth-capital financing to venture-capital-backed technology and life-sciences companies.
Hercules Capital (NYSE:HTGC) is a specialty-finance company and Business Development Company that provides venture debt and growth-capital financing to venture-capital-backed and institutionally backed companies, particularly in technology and life-sciences sectors. Shares closed at $17.72 at last closing, up 0.06%.
It earns income primarily from the interest and fees on its loans, along with potential upside from Equity and Warrant positions, and distributes most of its income to shareholders as dividends.
Latest Developments
In its second-quarter 2026 results, Hercules Capital reported record investment income, with earnings meeting estimates, contributing to first-half records, while the company pursued a notes offering. Investors should confirm the latest net investment income per share, net asset value per share, the Dividend and its coverage, Credit metrics, and new originations directly from SEC filings.
Financial and Business Position
As a venture-debt BDC, Hercules Capital's value rests on the quality of its Loan portfolio to venture- and growth-backed companies, its net asset value, and its ability to cover its dividend with net investment income. Investors should watch net investment income per share, credit metrics and non-accruals, and new originations and portfolio growth.
Stock-Market Context
HTGC shares closed at $17.72 at last closing, up 0.06%. The stock trades on its Dividend Yield and its price relative to net asset value, often at a premium reflecting its track record, and it is sensitive to credit conditions and the health of the venture ecosystem.
What Investors Should Watch
Watch net investment income per share and dividend coverage, net asset value per share, credit metrics and non-accruals, new originations and portfolio growth, leverage, and the health of the venture and growth-company market. Continued record or strong net investment income combined with healthy credit and steady originations would be the clearest signs of a positive surprise.






Please wait processing your request...